Is there a correlation between Gleason score and maximum standardized uptake value in locally advanced prostate cancer patients?

dc.contributor.authorCem, Onal
dc.contributor.authorTorun, Nese
dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorReyhan, Mehmet
dc.contributor.authorYildirim, Berna Akkus
dc.contributor.authorYapar, Ali Fuat
dc.contributor.orcID0000-0001-6908-3412en_US
dc.contributor.researcherIDAAC-5654-2020en_US
dc.date.accessioned2020-11-02T07:18:53Z
dc.date.available2020-11-02T07:18:53Z
dc.date.issued2019
dc.description.sponsorshipASCO; SITCen_US
dc.identifier.issn0732-183Xen_US
dc.identifier.issue7en_US
dc.identifier.urihttp://hdl.handle.net/11727/4986
dc.identifier.volume37en_US
dc.identifier.wos000489108800115en_US
dc.language.isoengen_US
dc.relation.isversionof10.1200/JCO.2019.37.7_suppl.68en_US
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleIs there a correlation between Gleason score and maximum standardized uptake value in locally advanced prostate cancer patients?en_US
dc.typeconferenceObjecten_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: